Document Detail


Society of Nuclear Medicine--57th annual meeting.
MedLine Citation:
PMID:  20721816     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The 57th Annual Meeting of the Society of Nuclear Medicine, held in Salt Lake City, UT, USA, included topics covering new developments in imaging agents and radiopharmaceutical therapies in the field of nuclear medicine. This conference report highlights selected presentations related to imaging of the brain, the prediction of heart disease, and the detection and treatment of various cancers. Investigational drugs discussed include TF-2 plus [68Ga]IMP-288 and TF-2 plus [111In]IMP-288 (both Immunomedics Inc), [11C]PBR-170 (Royal Prince Alfred Hospital/Australian Nuclear Science & Technology Organization), [11C]LY-2795050 (Eli Lilly & Co), yttrium (90Y) clivatuzumab tetraxetan (Garden State Cancer Center/Immunomedics Inc), [18F]LMI-1195 (Lantheus Medical Imaging Inc), fluciclovine (18F) (GE Healthcare/Nihon Medi-Physics Co Ltd), [99mTc]MIP-1340 and [99mTc]MIP-1407 (both Molecular Insight Pharmaceuticals Inc).
Authors:
Ben Searle
Related Documents :
19701746 - Society of skeletal radiology 2009 annual meeting.
21073306 - The australasian society for infectious diseases annual scientific meeting 2010.
21502096 - British thoracic society emergency oxygen audits.
19489696 - 25th annual meeting of the american electrophoresis society.
17734156 - Astronomers meet in phoenix, recount a stellar year.
22369076 - Introduction to the special section on ethical issues in clinical writing.
Publication Detail:
Type:  Congresses    
Journal Detail:
Title:  IDrugs : the investigational drugs journal     Volume:  13     ISSN:  2040-3410     ISO Abbreviation:  IDrugs     Publication Date:  2010 Aug 
Date Detail:
Created Date:  2010-08-19     Completed Date:  2010-12-13     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100883655     Medline TA:  IDrugs     Country:  England    
Other Details:
Languages:  eng     Pagination:  510-3     Citation Subset:  IM    
Affiliation:
Thomson Reuters, London, UK. ben.searle@thomsonreuters.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Brain / radionuclide imaging
Drug Evaluation, Preclinical
Drugs, Investigational / diagnostic use*,  therapeutic use*
Heart Diseases / radionuclide imaging
Humans
Neoplasms / radionuclide imaging,  therapy
Radiopharmaceuticals / diagnostic use*,  therapeutic use*
Chemical
Reg. No./Substance:
0/Drugs, Investigational; 0/Radiopharmaceuticals

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  American Society of Clinical Oncology--46th annual meeting.
Next Document:  32nd National Medicinal Chemistry Symposium--medicinal chemistry developments for neurodegeneration,...